A detailed history of Manufacturers Life Insurance Company, The transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 161,002 shares of FOLD stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
161,002
Previous 172,303 6.56%
Holding current value
$1.55 Million
Previous $1.71 Million 0.59%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$9.55 - $12.09 $107,924 - $136,629
-11,301 Reduced 6.56%
161,002 $1.72 Million
Q2 2024

Aug 14, 2024

BUY
$9.04 - $11.75 $76,921 - $99,980
8,509 Added 5.19%
172,303 $1.71 Million
Q1 2024

May 14, 2024

BUY
$11.43 - $14.24 $157,711 - $196,483
13,798 Added 9.2%
163,794 $1.93 Million
Q4 2023

Feb 13, 2024

SELL
$9.97 - $14.52 $528 - $769
-53 Reduced 0.04%
149,996 $2.13 Million
Q3 2023

Nov 15, 2023

BUY
$11.78 - $13.86 $431,960 - $508,232
36,669 Added 32.34%
150,049 $1.82 Million
Q2 2023

Aug 11, 2023

BUY
$10.72 - $13.3 $35,708 - $44,302
3,331 Added 3.03%
113,380 $1.42 Million
Q1 2023

May 15, 2023

BUY
$10.91 - $13.54 $14,433 - $17,913
1,323 Added 1.2%
111,372 $1.24 Million
Q4 2022

Aug 11, 2023

BUY
$9.89 - $12.7 $7,377 - $9,474
746 Added 0.68%
110,049 $1.34 Million
Q4 2022

Feb 13, 2023

BUY
$9.89 - $12.7 $7,377 - $9,474
746 Added 0.68%
110,049 $1.34 Million
Q3 2022

Aug 11, 2023

SELL
$9.82 - $12.75 $19,129 - $24,837
-1,948 Reduced 1.75%
109,303 $1.14 Million
Q3 2022

Nov 03, 2022

SELL
$9.82 - $12.75 $19,129 - $24,837
-1,948 Reduced 1.75%
109,303 $1.14 Million
Q2 2022

Aug 11, 2023

BUY
$6.23 - $11.12 $13,556 - $24,197
2,176 Added 1.99%
111,251 $1.19 Million
Q2 2022

Aug 15, 2022

BUY
$6.23 - $11.12 $13,556 - $24,197
2,176 Added 1.99%
111,251 $1.2 Million
Q1 2022

Aug 11, 2023

SELL
$7.89 - $12.48 $18,123 - $28,666
-2,297 Reduced 2.06%
109,075 $1.03 Million
Q1 2022

May 20, 2022

SELL
$7.89 - $12.48 $199,206 - $315,095
-25,248 Reduced 18.8%
109,075 $1.03 Million
Q4 2021

Feb 16, 2022

SELL
$9.82 - $12.44 $16,792 - $21,272
-1,710 Reduced 1.26%
134,323 $1.55 Million
Q3 2021

Nov 12, 2021

SELL
$8.74 - $11.84 $109,765 - $148,698
-12,559 Reduced 8.45%
136,033 $1.3 Million
Q2 2021

Aug 12, 2021

BUY
$8.71 - $10.72 $28,891 - $35,558
3,317 Added 2.28%
148,592 $1.43 Million
Q1 2021

May 03, 2021

SELL
$9.2 - $23.86 $73,756 - $191,285
-8,017 Reduced 5.23%
145,275 $1.44 Million
Q4 2020

Feb 12, 2021

BUY
$13.47 - $24.89 $85,116 - $157,279
6,319 Added 4.3%
153,292 $3.54 Million
Q3 2020

Nov 09, 2020

SELL
$12.89 - $15.89 $54,150 - $66,753
-4,201 Reduced 2.78%
146,973 $2.08 Million
Q2 2020

Aug 10, 2020

SELL
$8.86 - $15.69 $98,283 - $174,049
-11,093 Reduced 6.84%
151,174 $2.35 Million
Q1 2020

May 15, 2020

BUY
$6.63 - $11.16 $58,072 - $97,750
8,759 Added 5.71%
162,267 $1.5 Million
Q4 2019

Feb 14, 2020

SELL
$7.48 - $10.75 $13,007 - $18,694
-1,739 Reduced 1.12%
153,508 $1.5 Million
Q3 2019

Nov 12, 2019

BUY
$8.02 - $13.25 $18,093 - $29,892
2,256 Added 1.47%
155,247 $1.25 Million
Q2 2019

Aug 14, 2019

BUY
$10.96 - $14.4 $329,578 - $433,022
30,071 Added 24.46%
152,991 $1.91 Million
Q1 2019

May 13, 2019

SELL
$10.04 - $13.92 $65,621 - $90,981
-6,536 Reduced 5.05%
122,920 $1.67 Million
Q4 2018

Feb 14, 2019

BUY
$8.38 - $13.44 $59,003 - $94,631
7,041 Added 5.75%
129,456 $1.24 Million
Q3 2018

Nov 14, 2018

SELL
$11.6 - $16.54 $191,666 - $273,290
-16,523 Reduced 11.89%
122,415 $1.48 Million
Q2 2018

Aug 14, 2018

SELL
$13.13 - $17.09 $8,915 - $11,604
-679 Reduced 0.49%
138,938 $2.17 Million
Q1 2018

May 15, 2018

BUY
$13.76 - $17.12 $173,265 - $215,575
12,592 Added 9.91%
139,617 $2.1 Million
Q4 2017

Feb 08, 2018

BUY
$12.51 - $16.24 $20,979 - $27,234
1,677 Added 1.34%
127,025 $1.83 Million
Q3 2017

Nov 14, 2017

BUY
$11.74 - $15.78 $1.47 Million - $1.98 Million
125,348
125,348 $1.89 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.7B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.